UB Paderborn / Katalog / Suche / in CDI

The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial

The Journal of urology, 2013-03, Vol.189 (3), p.871-877

2013

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of a fixed‐dose combination of dutasteride and tamsulosin treatment (Duodart®) compared with watchful waiting with initiation of tamsulosin therapy if symptoms do not improve, both provided with lifestyle advice, in the management of treatment‐naïve men with moderately symptomatic benign prostatic hyperplasia: 2‐year CONDUCT study results

BJU international, 2015-09, Vol.116 (3), p.450-459

2015

Link zum Volltext

Verfügbarkeit prüfen

Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey

International journal of clinical practice (Esher), 2016-10, Vol.70 (10), p.870-880

2016

Link zum Volltext

Verfügbarkeit prüfen

A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

BJU international, 2018-04, Vol.121 (4), p.647-658

2018

Link zum Volltext

Verfügbarkeit prüfen

Indium-111 capromab pendetide in the management of recurrent prostate cancer

Expert review of anticancer therapy, 2008-02, Vol.8 (2), p.175-181

Manyak, Michael J

2008

Link zum Volltext

Verfügbarkeit prüfen

A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer

European journal of cancer (1990), 2015-08, Vol.51 (12), p.1555-1569

2015

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of a 3-item screening tool to identify men with benign prostatic enlargement/obstruction in a primary care cohort

Minerva urology and nephrology, 2022-02, Vol.74 (1), p.85

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study

International journal of clinical practice (Esher), 2019-09, Vol.73 (9), p.1-9

2019

Link zum Volltext

Verfügbarkeit prüfen

Men’s Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo‐controlled study

International journal of clinical practice (Esher), 2020-05, Vol.74 (5), p.e13480-n/a

2020

Link zum Volltext

Verfügbarkeit prüfen

Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations

Cancer epidemiology, biomarkers & prevention, 2017-11, Vol.26 (11), p.1660-1666

2017

Link zum Volltext

Verfügbarkeit prüfen

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

Cancer research (Chicago, Ill.), 2000-08, Vol.60 (16), p.4629-4637

2000

Link zum Volltext

Verfügbarkeit prüfen

Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers

The Prostate, 2017-12, Vol.77 (16), p.1573-1582

2017

Link zum Volltext

Verfügbarkeit prüfen

Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis

Journal of Biomedical Optics, 2008-03, Vol.13 (2), p.024003-024009

2008

Link zum Volltext

Verfügbarkeit prüfen

Malignant peripheral nerve sheath tumor of the kidney

International journal of urology, 2006-01, Vol.13 (1), p.74-75

2006

Link zum Volltext

Verfügbarkeit prüfen

Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study

World journal of urology, 2017-03, Vol.35 (3), p.421-427

2017

Link zum Volltext

Verfügbarkeit prüfen

Relative Bioavailability of Fixed‐Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male Volunteers

Clinical pharmacology in drug development, 2018-05, Vol.7 (4), p.422-434

2018

Link zum Volltext

Verfügbarkeit prüfen

Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium

Journal of endourology, 2003-10, Vol.17 (8), p.633-639

2003

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography

Journal of endourology, 2005-06, Vol.19 (5), p.570-574

2005

Link zum Volltext

Verfügbarkeit prüfen

The emergence of imaging technology in advanced prostate cancer

Canadian journal of urology, 2007-12, Vol.14 Suppl 1, p.32

Manyak, Michael J

2007

Link zum Volltext

Verfügbarkeit prüfen

Central Abdominal Uptake of Indium-111 Capromab Pendetide (ProstaScint) Predicts for Poor Prognosis in Patients with Prostate Cancer

Urology (Ridgewood, N.J.), 2007-08, Vol.70 (2), p.303-308

2007

Link zum Volltext

Verfügbarkeit prüfen

MP40-12 ESTABLISHING A MINIMAL CLINICALLY MEANINGFUL DIFFERENCE IN THE MSHQ: NEW INSIGHTS

The Journal of urology, 2019-04, Vol.201 (Supplement 4)

2019

Link zum Volltext

Verfügbarkeit prüfen

The Evolution of Imaging in Advanced Prostate Cancer

Urologic clinics of North America, 2006-05, Vol.33 (2), p.133-146

2006

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I—methods

Urology (Ridgewood, N.J.), 2000-12, Vol.56 (6), p.972-980

2000

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results

Urology (Ridgewood, N.J.), 2000-12, Vol.56 (6), p.981-987

2000

Link zum Volltext

Verfügbarkeit prüfen

Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy

Journal of endourology, 2002-02, Vol.16 (1), p.51-56

2002

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The REDUCE Follow-Up Study: Low Rate of New Prostate Cancer Diagnoses Observed During a 2-Year, Observational, Followup Study of Men Who Participated in the REDUCE Trial

Understanding patient and physician perceptions of benign prostatic hyperplasia in Asia Pacific, Latin America and the Commonwealth of Independent States: the Prostate Research on Behaviour and Education (PROBE) II survey

A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

Indium-111 capromab pendetide in the management of recurrent prostate cancer

A randomised, double-blind study comparing the addition of bicalutamide with or without dutasteride to GnRH analogue therapy in men with non-metastatic castrate-resistant prostate cancer

Evaluation of a 3-item screening tool to identify men with benign prostatic enlargement/obstruction in a primary care cohort

Evaluation of the impact of dutasteride/tamsulosin combination therapy on libido in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH): A post hoc analysis of a prospective randomised placebo-controlled study

Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations

Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases

Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers

Computer recognition of cancer in the urinary bladder using optical coherence tomography and texture analysis

Malignant peripheral nerve sheath tumor of the kidney

Can we use baseline characteristics to assess which men with moderately symptomatic benign prostatic hyperplasia at risk of progression will benefit from treatment? A post hoc analysis of data from the 2-year CONDUCT study

Relative Bioavailability of Fixed‐Dose Combinations of Tamsulosin and Dutasteride: Results From 2 Randomized Trials in Healthy Male Volunteers

Photodynamic therapy for refractory superficial bladder cancer: long-term clinical outcomes of single treatment using intravesical diffusion medium

Evaluation of superficial bladder transitional-cell carcinoma by optical coherence tomography

The emergence of imaging technology in advanced prostate cancer

Central Abdominal Uptake of Indium-111 Capromab Pendetide (ProstaScint) Predicts for Poor Prognosis in Patients with Prostate Cancer

MP40-12 ESTABLISHING A MINIMAL CLINICALLY MEANINGFUL DIFFERENCE IN THE MSHQ: NEW INSIGHTS

The Evolution of Imaging in Advanced Prostate Cancer

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I—methods

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II—results

Cost effectiveness of treatment for benign prostatic hyperplasia: an economic model for comparison of medical, minimally invasive, and surgical therapy

Suchergebnisse filtern